View Item 

Show simple item record

Functional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study

dc.contributor.authorWoodcock, Eric A.en_US
dc.contributor.authorLundahl, Leslie H.en_US
dc.contributor.authorBurmeister, Margiten_US
dc.contributor.authorGreenwald, Mark K.en_US
dc.date.accessioned2015-06-01T18:51:47Z
dc.date.available2016-07-05T17:27:58Zen
dc.date.issued2015-06en_US
dc.identifier.citationWoodcock, Eric A.; Lundahl, Leslie H.; Burmeister, Margit; Greenwald, Mark K. (2015). "Functional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study." The American Journal on Addictions 24(4): 329-335.en_US
dc.identifier.issn1055-0496en_US
dc.identifier.issn1521-0391en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/111777
dc.publisherSage Publicationsen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleFunctional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot studyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/111777/1/ajad12187.pdf
dc.identifier.doi10.1111/ajad.12187en_US
dc.identifier.sourceThe American Journal on Addictionsen_US
dc.identifier.citedreferenceRickham PP. Human experimentation. Code of ethics of the World Medical Association Declaration of Helsinki. Br Med J. 1964; 2: 177.en_US
dc.identifier.citedreferenceManini AF, Jacobs MM, Vlahov D, et al. Opioid receptor polymorphism A 118 G associated with clinical severity in a drug overdose population. J Med Toxicol. 2013; 2: 148 – 154. DOI: 10.1007/s13181‐012‐0286‐3.en_US
dc.identifier.citedreferenceWang YJ, Huang P, Ung A, et al. Reduced expression of the mu opioid receptor in some, but not all, brain regions in mice with OPRM1 A 112 G. Neuroscience. 2012b; 205: 178 – 184. DOI: 10.1016/j.neuroscience.2011.12.033en_US
dc.identifier.citedreferenceGreenwald MK, Hursh SR. Behavioral economic analysis of opioid consumption in heroin‐dependent individuals: Effects of unit price and pre‐session drug supply. Drug Alcohol Depend. 2006; 85: 35 – 48. DOI: 10.1016/j.drugalcdep.2006.03.007en_US
dc.identifier.citedreferenceGreenwald MK, Steinmiller CL. Behavioral economic analysis of opioid consumption in heroin‐dependent individuals: Effects of alternative reinforcer magnitude and post‐session drug supply. Drug Alcohol Depend. 2009; 104: 84 – 93. DOI: 10.1016/j.drugalcdep.2009.04.006en_US
dc.identifier.citedreferenceGreenwald MK. Effects of experimental unemployment, employment and punishment analogs on opioid seeking and consumption in heroin‐dependent volunteers. Drug Alcohol Depend. 2010; 111: 64 – 73. DOI: 10.1016/j.drugalcdep.2010.03.020en_US
dc.identifier.citedreferenceGreenwald MK, Lundahl LH, Steinmiller CL. Yohimbine increases opioid‐seeking behavior in heroin‐dependent, buprenorphine‐maintained individuals. Psychopharmacology. 2013; 225: 811 – 824. DOI: 10.1007/s00213‐012‐2868‐9.en_US
dc.identifier.citedreferenceHodgkinson CA, Yuan Q, Xu K, et al. Addictions biology: Haplotype‐based analysis for 130 candidate genes on a single array. Alcohol Alcohol. 2008; 43: 505 – 515. DOI: 10.1093/alcalc/agn032en_US
dc.identifier.citedreferenceWest S.G., Finch J.F., Curran P.J., Structural equation models with nonnormal variables: Problems and remedies R.H. Hoyle, Structural equation modeling: Concepts, issues, and applications 1995 Newberry Park, CA: Sage Publications; 56 – 75.en_US
dc.identifier.citedreferenceBarrio G, De La Fuente L, Lew C, et al. Differences in severity of heroin dependence by route of administration: The importance of length of heroin use. Drug Alcohol Depend. 2001; 63: 169 – 177. DOI: 10.1016/S0376‐8716(00)00204‐0.en_US
dc.identifier.citedreferenceGossop M, Griffiths P, Powis B, et al. Severity of dependence and route of administration of heroin, cocaine, and amphetamines. Br J Addict. 1992; 87: 1527 – 1536.en_US
dc.identifier.citedreferenceSmolka M, Schmidt LG. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction. 1999; 94: 1191 – 1198. DOI: 10.1046/j.1360‐0443en_US
dc.identifier.citedreferenceSmyth BP, Barry J, Keenan E, et al. Lapse and relapse following treatment of opiate dependence. Ir Med J. 2010; 103: 176 – 179.en_US
dc.identifier.citedreferenceRay R, Jepson C, Patterson F, et al. Association of OPRM1 A 118 G variant with the relative reinforcing value of nicotine. Psychopharmacology (Berl). 2006; 188: 355 – 363. DOI: 10.1007/s00213‐006‐0504‐2.en_US
dc.identifier.citedreferenceMunafò MR, Elliot KM, Murphy MF, et al. Association of the mu‐opioid receptor gene with smoking cessation. Pharmacogenomics J. 2007; 7: 353 – 361. DOI: 10.1038/sj.tpj.6500432en_US
dc.identifier.citedreferenceKim SG. Gender differences in the genetic risk for alcohol dependence ‐ The results of a pharmacogenetic study in Korean alcoholics. Japanese Journal of Alcohol Studies & Drug Dependence 2009; 44: 680 – 685.en_US
dc.identifier.citedreferenceFillingim RB, Kaplan L, Staud R, et al. The A 118 G single nucleotide polymorphism of the μ‐opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005; 6: 159 – 167. DOI: 10.1016/j.jpain.2004.11.008en_US
dc.identifier.citedreferenceRaynor K, Kong H, Chen Y, et al. Pharmacological characterization of the cloned kappa‐, delta‐, and mu‐opioid receptors. Mol Pharmacol. 1994; 45: 330 – 334.en_US
dc.identifier.citedreferenceLalley PM. Opioidergic and dopaminergic modulation of respiration. Respir Physiol Neurobiol. 2008; 164: 160 – 167. DOI: 10.1016/j.resp.2008.02.004en_US
dc.identifier.citedreferenceZhang Z, Zhuang J, Zhang C, et al. Activation of opioid μ‐receptors in the commissural subdivision of the nucleus tractus solitarius abolishes the ventilatory response to hypoxia in anesthetized rats. Anesthesiology 2011; 115: 353 – 363. DOI: 10.1097/ALN.0b013e318224cc1fen_US
dc.identifier.citedreferenceBergen AW, Kokoszka J, Peterson R, et al. Mu opioid receptor gene variants: Lack of association with alcohol dependence. Mol Psychiatry. 1997; 2: 490 – 494. DOI: 10.1038/sj.mp.4000331en_US
dc.identifier.citedreferenceBond C, LaForge KS, Tian M, et al. Single‐nucleotide polymorphism in the human mu opioid receptor gene alters β‐endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci USA. 1998; 95: 9608 – 9613.en_US
dc.identifier.citedreferenceZhang Y, Wang D, Johnson AD, et al. Allelic expression imbalance of human mu opioid receptor ( OPRM1 ) caused by variant A 118 G. J Biol Chem. 2005; 280: 32618 – 32624. DOI: 10.1074/jbc.M504942200en_US
dc.identifier.citedreferenceOertel BG, Doehring A, Roskam B, et al. Genetic‐epigenetic interaction modulates μ‐opioid receptor regulation. Hum Mol Genet. 2012; 21: 4751 – 4760. DOI: 10.1093/hmg/dds314en_US
dc.identifier.citedreferenceWang YJ, Huang P, Blendy JA, et al. Brain region‐ and sex‐specific alterations in DAMGO‐stimulated [(35) S]GTPgammaS binding in mice with OPRM1 A 112 G. Addict Biol. 2012a; 19: 354 – 361. DOI: 10.1111/j.1369‐1600.2012.00484.xen_US
dc.identifier.citedreferenceYaksh TL, Yeung JC, Rudy TA. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray. Brain Res. 1976; 114: 83 – 103.en_US
dc.identifier.citedreferenceIngvar M. Pain and functional imaging. Philos Trans R Soc Lond B Biol Sci. 1999; 354: 1347 – 1358. DOI: 10.1098/rstb.1999.0483en_US
dc.identifier.citedreferencePeyron R, Laurent B, Garcia‐Larrea L. Functional imaging of brain responses to pain. A review and meta‐analysis. Clin Neurophysiol. 2000; 30: 263 – 288. DOI: 10.1016/S0987‐7053(00)00227‐6.en_US
dc.identifier.citedreferenceMague SD, Isiegas C, Huang P, et al. Mouse model of OPRM1 (A 118 G) polymorphism has sex‐specific effects on drug‐mediated behavior. Proc Natl Acad Sci USA. 2009; 106: 10847 – 10852. DOI: 10.1073/pnas.0901800106en_US
dc.identifier.citedreferenceChou WY, Wang CH, Liu PH. Human opioid receptor A 118 G polymorphism affects intravenous patient‐controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology. 2006a; 105: 334 – 337.en_US
dc.identifier.citedreferenceChou WY, Yang LC, Lu HF, et al. Association of mu‐opioid receptor gene polymorphism (A 118 G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand. 2006b; 50: 787 – 792. DOI: 10.1111/j.1399‐6576.2006.01058.xen_US
dc.identifier.citedreferenceSia AT, Lim Y, Lim EC, et al. A 118 G single nucleotide polymorphism of human mu‐opioid receptor gene influences pain perception and patient‐controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008; 109: 520 – 526. DOI: 10.1097/ALN.0b013e318182af21en_US
dc.identifier.citedreferenceTan EC, Lim EC, Teo YY, et al. Ethnicity and OPRM1 variant independently predict pain perception and patient‐controlled analgesia usage for post‐operative pain. Mol Pain. 2009; 5: 1 – 8. DOI: 10.1186/1744‐8069‐5‐32.en_US
dc.identifier.citedreferenceHuang P, Chen C, Mague SD, et al. A common single nucleotide polymorphism A 118 G of the mu opioid receptor alters its N‐glycosylation and protein stability. Biochem J. 2012; 441: 379 – 386. DOI: 10.1042/BJ20111050en_US
dc.identifier.citedreferenceBeyer A, Koch T, Schroder H, et al. Effect of the A 118 G polymorphism on binding affinity, potency, and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu ‐opioid receptor. J Neurochem. 2004; 89: 553 – 560. DOI: 10.1111/j.1471‐4159.2004.02340.xen_US
dc.identifier.citedreferenceKroslak T, LaForge KS, Gianotti RJ, et al. The single nucleotide polymorphism A 118 G alters functional properties of the human mu opioid receptor. J Neurochem. 2007; 103: 77 – 87. DOI: 10.1111/j.1471‐4159.2007.04738.xen_US
dc.identifier.citedreferenceRay R, Ruparel K, Newberg A, et al. Human mu opioid receptor (OPRM1 A 118 G) polymorphism is associated with brain mu‐opioid receptor binding potential in smokers. Proc Natl Acad Sci USA. 2011; 108: 9268 – 9273. DOI: 10.1073/pnas.1018699108en_US
dc.identifier.citedreferenceWeerts EM, McCaul ME, Kuwabara H, et al. Influence of OPRM1 Asn40Asp variant (A 118 G) on [11C]carfentanil binding potential: Preliminary findings in human subjects. Int J Neuropsychopharmacol. 2013; 16: 47 – 53. DOI: 10.1017/S146114571200017Xen_US
dc.identifier.citedreferenceColler JK, Beardsley J, Bignold J, et al. Lack of association between the A 118 G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta‐analysis. Pharmacogenomics Pers Med. 2009; 2: 9 – 19.en_US
dc.identifier.citedreferenceArias A, Feinn R, Kranzler HR. Association of an Asn40Asp (A 118 G) polymorphism in the μ‐opioid receptor gene with substance dependence: A meta analysis. Drug Alcohol Depend. 2006; 83: 262 – 268. DOI: 10.1016/j.drugalcdep.2005.11.024en_US
dc.identifier.citedreferenceHaerian BS, Haerian MS. OPRM1 rs1799971 polymorphism and opioid dependence: Evidence from a meta‐analysis. Pharmacogenomics. 2013; 7: 813 – 824. DOI: 10.2217/pgs.13.57en_US
dc.identifier.citedreferenceKreek MJ, Nielsen DA, Butelman ER, et al. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience. 2005; 8: 1450 – 1457. DOI: 10.1038/nn1583en_US
dc.identifier.citedreferenceKhokhar JY, Ferguson CS, Zhu AZ, et al. Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. Annu Rev Pharmacol Toxicol. 2010; 50: 39 – 61. DOI: 10.1146/annurev.pharmtox.010909.105826en_US
dc.identifier.citedreferenceNikolov MA, Beltcheva O, Galabova A, et al. No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case‐control sample. Drug Alcohol Depend. 2011; 117: 62 – 65. DOI: 10.1016/j.drugalcdep.2010.12.026en_US
dc.identifier.citedreferenceShi J, Hui L, Xu Y, et al. Sequence variations in the mu‐opioid receptor gene (OPRM1) associated with human addiction to heroin. Human Mutat. 2002; 19: 459 – 460. DOI: 10.1002/humu.9026en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ajad12187.pdf
Size:
160.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.